General Description
Trimebutine is a drug with antimuscarinic and weak mu opioid agonist effects.[1] The maleic acid salt of trimebutine is marketed under the trademarks of Debridat, Recutin, Polybutin,[2] or Modulon, for the treatment of irritable bowel syndrome and other gastrointestinal disorders.